dermveda ULTRA BALANITIS RELIEF

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: dermveda ULTRA BALANITIS RELIEF
Generic name: CARDIOSPERMUM, CURCUMA LONGA
Manufacturer: Celcius Corp.
Product type: HUMAN OTC DRUG
SPL set ID: ab44b4af-f712-411e-9c2a-92fedb931ef2
SPL ID: 7659bda6-ed60-4559-a80a-96d5d030fd1d
Version: 1
Effective date: 2026-08-11
Source export date: 2026-09-28
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/db99fd80353afecef4949b48edcaa018be72b966b2360184251eb14df43743f9/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:41:29

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		dermveda ULTRA BALANITIS RELIEF	openfda.brand_name
generic name		CARDIOSPERMUM, CURCUMA LONGA	openfda.generic_name
manufacturer name		Celcius Corp.	openfda.manufacturer_name
ndc	package	83819-987-02	openfda.package_ndc
ndc	product	83819-987	openfda.product_ndc
ndc11	package	83819098702	derived:openfda.package_ndc
spl id		7659bda6-ed60-4559-a80a-96d5d030fd1d	id
spl set id		ab44b4af-f712-411e-9c2a-92fedb931ef2	set_id
unii		MZP2508BRR	openfda.unii
unii		856YO1Z64F	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Product is not FDA evaluated and will not cure Balanitis, will not prevent future outbreaks and will not stop the spread of Balanitis. When using this product • Apply the product exclusively to affected areas. • Avoid application near or around the eyes. • Do not share this product with others to mitigate the risk of infection or viral transmission. Stop use and ask a doctor if • If symptoms persist or inflammation increases after weeks of use or if the itch increases. • Increase in redness on skin. Pregnant or Breast Feeding • Ask a Health Professional before use. Keep out of reach of children. If swallowed, get medical help or contact a poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.